Inventors

Bioventures' Pathway to Patents

The invention disclosure process can be overwhelming at times, which is why we have broken down the step by step process for you. Here you can read the timeline in a simple and clear way. If you are an inventor, click here to read a more detailed description of the process.

Step 1
Invention Disclosure

Submit the invention disclosure form stating the current status of your invention.

 

Step 2
Technology Assessment Report

Our team will complete the TAR, a structured summative document regarding your invention. This includes a snapshot of colesely related inventions, and preliminary market analysis.

Step 3
Technology Assessment Deck

The slide deck helps us focus the technology assessment report even more and allows us to send the information to individuals in the industry to help us assess the technology.

Step 4
Patent and Copyright Committee Presentation

The Bioventures team preset the technology to the Committee with the collaboration of the inventor.

Step 6
Determination

After the Patent and Copyright Committee meet, there are 3 possible determinations. 

Start now!

To start the process, the first step is to fill out the Invention Disclosure Questionnaire. Log in to Wellspring Sophia and click “Login through UAMS”.

SUBMIT INVENTION

Latest News and Updates
Blog
Bioventures Team

BioVentures Receives 2025 Growth Accelerator Fund Competition Award from the U.S. Small Business Administration 

BioVentures has been selected as one of the awardees of the 2025 Growth Accelerator Fund Competition (GAFC), a program of the U.S. Small Business Administration (SBA) designed to support the growth of science and technology-based startups across the United States.  The GAFC program aims to encourage innovative approaches that accelerate the commercialization of emerging technologies and strengthen national entrepreneurship networks. Awardees in the 2025 competition receive $75,000 to implement initiatives that address challenges within their local innovation ecosystems.   BioVentures received an award under the Lab-to-Market category, focused on transitioning research into market-ready technologies. Through this award, BioVentures seeks to enhance the statewide culture for innovation and entrepreneurship in health by launching targeted statewide entrepreneurial programming, enhancing mentorship networks, and connecting with national biotechnology leaders.   A list of all  2025 GAFC awardees is available through the official channels of the U.S. Small Business Administration.  For questions or additional information, please contact bioventures@uams.edu

See More »
December 11, 2025
Events
Bioventures Team

BioVentures participates in AUTM University Conference 2025 in New Orleans  

BioVentures participated in the AUTM University Conference 2025, held from October 26–29 in New Orleans. The event brought together professionals from technology transfer offices across the country to exchange knowledge, explore emerging trends, and strengthen collaboration within the tech transfer community.  The conference offered a valuable opportunity to learn from experts, exchange best practices, and strengthen collaboration across the national tech transfer network.  “From insightful sessions to meaningful networking moments, this experience was truly inspiring,” said Britney Bobo, Project Coordinator at BioVentures. “I had the chance to learn from industry experts, share ideas with peers, and dive deeper into the evolving world of tech transfer and innovation.”  By taking part in AUTM University, BioVentures reinforces its commitment to advancing technology commercialization and promoting innovation through collaboration and professional development. 

See More »
November 12, 2025
See All

Subscribe to our Newsletter

Stay tuned with BioVentures’ newsletter for inventors: news, events, resources and more!

* indicates required